BSX Q2 2024 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4.1B+14.5% YoY

Gross Profit

$2.6B62.7% margin

Operating Income

$747M18.1% margin

Net Income

$324M7.9% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+6.8%

Cash Flow

Operating Cash Flow

$813M

Free Cash Flow

$658M

Stock-Based Comp.

$195M

Balance Sheet

Total Assets

$37.1B

Total Liabilities

$16.5B

Stockholders' Equity

$20.4B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.1B	$3.6B	+14.5%
Gross Profit	$2.6B	$2.3B	+13.6%
Operating Income	$747M	$551M	+35.6%
Net Income	$324M	$270M	+20.0%

Revenue Segments

Cardiovascular

$2.6B64%

MedSurg

$1.5B36%

Geographic Segments

UNITED STATES

$2.5B60%

Non-US

$1.7B40%